Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auriclosene in bacterial conjunctivitis
NCT01877694Phase 2Completed
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of auriclosene in bacterial conjunctivitis (BC), sponsored by NovaBay Pharmaceuticals, Inc.. Started Jun 2013; status: completed.
02
Drugs
auriclosene
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT01877694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01877694.